Inactive Instrument

Highlights Endonovo Therapeutics, Inc. Other OTC

Equities

ENDV

US29272H3003

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Dec. 29	CI
Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval	23-10-12	CI
Endonovo Therapeutics, Inc.'s SofPulse Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution	23-08-22	CI
Endonovo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Endonovo Therapeutics, Inc. Announces Pending Agreement to Develop Telehealth Division	23-06-07	CI
Endonovo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
Endonovo Therapeutics, Inc. Launches SofPulse into the Veterans Administration	23-05-02	CI
Endonovo Therapeutics, Inc. Announces Moving Forward in Its Clinical Development in the Field of Traumatic Brain Injury Treatment	23-04-25	CI
Endonovo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
Endonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Company	23-03-29	AQ
Endonovo Therapeutics, Inc. Announces Final Stages to Receive Taiwan FDA License to Distribute in Taiwan	23-03-23	CI
Endonovo Announces Distribution Agreement with Academy Medical	23-03-06	CI
Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off	23-01-31	AQ
Endonovo Partners with International Distributor for SofPulse Line	23-01-26	CI
New Details on Endonovo’s Spin-Off of SofPulse, Inc.	23-01-19	AQ
Endonovo Therapeutics Details Plan to Spin Off Medical Device Division as A Listed Public Company	23-01-09	CI
Endonovo Therapeutics Details Plan to Spin Off Medical Device Division as a Listed Public Company	23-01-09	AQ
Endonovo Therapeutics, Inc. agreed to Spin-Off Medical Device Division of Endonovo Therapeutics.	23-01-08	CI
Endonovo Announces Plans for Spin-off of Medical IP and Assets	22-12-15	AQ
Endonovo Names Ira Weisberg President to Guide Global Medical Expansion	22-11-30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Endonovo Therapeutics, Inc. Other OTC

Equities

ENDV

US29272H3003

Highlights

Filters